Risk Factor, Cardiovascular
36
4
5
23
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 36 trials
100.0%
+13.5% vs benchmark
3%
1 trials in Phase 3/4
9%
2 of 23 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 23 completed trials
Clinical Trials (36)
Myocardial Injury in Noncardiac Surgery in Sweden
Cardiovascular Effects of CART Cell Therapy
Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab
FIND Stroke Recovery - A Longitudinal Study
Individual Factors Related to Chronic Low-grade Inflammation and Cardiometabolic Disease Risk
Telematic Model Integrated in the Transversal Care of the Secondary Prevention of Patients With Stroke
Prospective Urban Rural Epidemiology Study
Analysis of Health Status of Сomorbid Adult COVID-19 Patients Hospitalised in Second Wave of SARS-CoV-2 Infection
Women's Assessed Cardiovascular Evaluation With MCG
Preventing Cognitive Decline: The CITA GO-ON Multi-domain Intervention Study
Determining the Age of First Acute Coronary Syndrome
ICU Trial in Critical Ill COVID-19 Patients
Hybridized Three Steps Intervention to Prevent Diabetes in Venezuela
Prognostic Accuracy of the HEART Score in Undifferentiated Chest Pain: A Multicenter Validation Study
Effectiveness of Stroke Riskometer Apps In Improving Awareness and Stroke Risk Probability
Cardiovascular Risk in People Older Than 55 Years and Cognitive Performance at 5 Years
ICF in Secondary Prevention of Cardiovascular Disease
Home-based HIIT in a Primary-care Setting for at Risk Individuals: A Multidisciplinary Approach
Optimized Management of Covid-19 Positive Kidney Transplant Recipients: Single Center Experience From the Middle East
Inclisiran for Subjects With ASCVD or ASCVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol